KIDS - OrthoPediatrics Corp.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
46.30
+0.17 (+0.37%)
At close: 4:00PM EDT

46.46 +0.16 (0.35%)
After hours: 4:11PM EDT

Stock chart is not supported by your current browser
Previous Close46.13
Open45.87
Bid46.34 x 1100
Ask46.43 x 800
Day's Range45.74 - 47.31
52 Week Range28.19 - 51.48
Volume73,023
Avg. Volume130,633
Market Cap824.992M
Beta (5Y Monthly)0.77
PE Ratio (TTM)N/A
EPS (TTM)-1.03
Earnings DateMay 05, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est49.50
  • GlobeNewswire

    OrthoPediatrics Corp. to Continue Sponsorship for 2020 POSNA Annual Meeting

    OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced the Company’s continued Double-Diamond sponsorship for the virtual 2020 Pediatric Orthopaedic Society of North America (“POSNA”) Annual Meeting, which will open online May 13, 2020 and remain available until December 31, 2020. OrthoPediatrics retains its designation as a Double Diamond Sponsor with additional sponsorship of specialty symposiums as well as support of educational grants. In addition to its ongoing commitments, the Company will also utilize a virtual display to highlight the PediFoot Deformity Correction (“PediFoot”) System, Next Generation Cannulated Screw Systems, and QuickPack™, all of which were recently introduced in the U.S. in the second half of 2019.

  • OrthoPediatrics Corp. (KIDS) Q1 2020 Earnings Call Transcript
    Motley Fool

    OrthoPediatrics Corp. (KIDS) Q1 2020 Earnings Call Transcript

    Ladies and gentlemen, thank you for standing by, and welcome to the Q1 2020 OrthoPediatrics Corp Earnings Conference Call. Joining me from the Company are Mark Throdahl, Chief Executive Officer; Fred Hite, Chief Financial Officer; and David Bailey, Executive Vice President.

  • OrthoPediatrics (KIDS) Reports Q1 Loss, Misses Revenue Estimates
    Zacks

    OrthoPediatrics (KIDS) Reports Q1 Loss, Misses Revenue Estimates

    OrthoPediatrics (KIDS) delivered earnings and revenue surprises of -11.11% and -3.52%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

  • GlobeNewswire

    OrthoPediatrics Corp. Reports First Quarter 2020 Financial Results

    WARSAW, Ind., May 05, 2020 -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq:KIDS), a company focused exclusively on advancing the field of pediatric.

  • GlobeNewswire

    OrthoPediatrics Corp. to Participate in the 6th Annual SunTrust Robinson Humphrey Life Sciences Summit

    WARSAW, Ind., April 29, 2020 -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq:KIDS), a company focused exclusively on advancing the field of pediatric.

  • Analysts Estimate OrthoPediatrics (KIDS) to Report a Decline in Earnings: What to Look Out for
    Zacks

    Analysts Estimate OrthoPediatrics (KIDS) to Report a Decline in Earnings: What to Look Out for

    OrthoPediatrics (KIDS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • GlobeNewswire

    OrthoPediatrics Corp. to Report First Quarter 2020 Financial Results on May 5, 2020

    OrthoPediatrics Corp. (“OrthoPediatrics”) (KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today that the Company is scheduled to release its first quarter 2020 financial results on Tuesday, May 5, 2020, after the market closes. OrthoPediatrics will host a conference call on Wednesday, May 6, 2020, at 8:00 a.m. ET to discuss the results. The dial-in numbers are (855) 289-4603 for domestic callers and (614) 999-9389 for international callers.

  • GlobeNewswire

    OrthoPediatrics Corp. Announces Acquisition of ApiFix Ltd. with FDA-Approved Non-Fusion Scoliosis Technology

    OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, is pleased to announce that it has acquired ApiFix Ltd. (“ApiFix”), including its minimally invasive deformity correction (“MID-C”) system for non-fusion treatment of progressive adolescent idiopathic scoliosis (“AIS”), for 934,768 shares of OrthoPediatrics common stock and $2 million in cash paid at closing, plus milestone payments and an earnout over a period of four years. ApiFix Ltd. is an Israel and Boston, MA based medical device company with a less invasive spinal deformity correction system for non-fusion treatment of progressive AIS.

  • GlobeNewswire

    OrthoPediatrics Corp. Receives FDA 510(k) Clearance and Expanded Neuromuscular Indications for its RESPONSE™ Scoliosis System

    OrthoPediatrics Corp. (“OrthoPediatrics”) (KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration to expand the indications for its RESPONSE™ Scoliosis System to include neuromuscular implants. This 510(k) clearance represents a significant milestone in the Company’s development toward its next generation RESPONSE Scoliosis System, RESPONSE™ NeuroMuscular (“RESPONSE – NM”). This new system will be entirely dedicated to the treatment of neuromuscular scoliosis in pediatrics and builds on existing product offerings focused on treating this unique class of patients.

  • GlobeNewswire

    OrthoPediatrics Corp. Provides COVID-19 Business Update

    OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today provided a business update on the proactive steps it is taking in response to the global COVID-19 pandemic. As hospitals globally postpone elective procedures to generate capacity for treating COVID-19 patients, the Company is withdrawing its previously announced 2020 revenue guidance of growth in the range of 22%-24% and investment in consignment sets in a range of $19-$21 million.

  • Is OrthoPediatrics (NASDAQ:KIDS) Weighed On By Its Debt Load?
    Simply Wall St.

    Is OrthoPediatrics (NASDAQ:KIDS) Weighed On By Its Debt Load?

    Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

  • OrthoPediatrics Announces Latest Screw System Launch in US
    Zacks

    OrthoPediatrics Announces Latest Screw System Launch in US

    OrthoPediatrics (KIDS) releases the latest cannulated screw system as part of its beta release to address trauma as well as other bone fixation procedures.

  • GlobeNewswire

    OrthoPediatrics Corp. Announces U.S. Launch of Large Fragment Cannulated Screw System

    WARSAW, Ind., March 09, 2020 -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric.

  • OrthoPediatrics (KIDS) Reports Q4 Loss, Tops Revenue Estimates
    Zacks

    OrthoPediatrics (KIDS) Reports Q4 Loss, Tops Revenue Estimates

    OrthoPediatrics (KIDS) delivered earnings and revenue surprises of -16.00% and 3.79%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

  • GlobeNewswire

    OrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2019 Financial Results

    Consecutive year of record annual revenue with 26.0% year-over-year growth to $72.6 million Full year 2020 revenue growth guidance in the range of 22% to 24% WARSAW, Ind.,.

  • GlobeNewswire

    OrthoPediatrics Corp. Announces Direct Sales Agency Expansion in Italy

    OrthoPediatrics Corp. (“OrthoPediatrics”) (KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, today announced an updated agreement with Medical 2011 S.r.l. Medical 2011 has served as OrthoPediatrics’ stocking distributor since 2013 and under the terms of the agreement, OrthoPediatrics will sell direct to hospitals in Italy with Medical 2011 as the Company’s exclusive sales agency.

  • GlobeNewswire

    OrthoPediatrics Corp. to Highlight its Pediatric Scoliosis Solutions at 6th Annual International Children’s Spine Symposium (ICSS)

    OrthoPediatrics Corp. (“OrthoPediatrics”) (KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced it will attend the 6th Annual International Children’s Spine Symposium (ICSS), which will take place March 13-14, 2020 in Orlando, Florida. As such it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions.

  • GlobeNewswire

    OrthoPediatrics Corp. Continues to be Honored as One of the Best Place to Work in Indiana

    OrthoPediatrics Corp. (KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, is pleased to announce that it was recently named  one of the Best Places to Work in Indiana by the Indiana Chamber of Commerce and Best Companies Group. OrthoPediatrics’ recognition and inclusion in the fifteenth annual program is the fourth time the Company has been honored with this award. This survey and awards program were designed to identify, recognize and honor the best employers in Indiana, benefiting the state’s economy, workforce and businesses.

  • GlobeNewswire

    OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2019 Financial Results on March 4, 2020

    OrthoPediatrics Corp. (“OrthoPediatrics”) (KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today that the Company is scheduled to release its fourth quarter and full year 2019 financial results on Wednesday, March 4, 2020, after the market closes. OrthoPediatrics will host a conference call on Thursday, March 5, 2020, at 8:00 a.m. ET to discuss the results. The dial-in numbers are (855) 289-4603 for domestic callers and (614) 999-9389 for international callers.

  • GlobeNewswire

    OrthoPediatrics Corp. Reports Preliminary Unaudited Revenue for Fourth Quarter and Record Setting Full Year 2019

    WARSAW, Ind., Jan. 13, 2020 -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today.

  • GlobeNewswire

    OrthoPediatrics Corp. Announces Divestiture of the Vilex Adult Business

    OrthoPediatrics Corp. (“OrthoPediatrics”) (KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that it has completed the sale of substantially all of the assets related to the adult product offering of Vilex in Tennessee, Inc. (“Vilex Adult Business”) to Vilex LLC (“Buyer”), an affiliate of Squadron Capital LLC (“Squadron Capital”). In addition, Buyer was granted a license to manufacture and sell products utilizing the external fixation technology developed by Orthex, LLC, an affiliate of OrthoPediatrics, subject to certain restrictions in favor of OrthoPediatrics on sales to certain pediatric accounts.

  • GlobeNewswire

    OrthoPediatrics Corp. Announces U.S. Launch of QuickPack™

    OrthoPediatrics Corp. (“OrthoPediatrics”) (KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, is pleased to announce the U.S. launch of QuickPack™, a fully synthetic bone graft substitute featuring a high viscosity, calcium phosphate cement that closely mimics the mineral phase of natural bone. With mechanical properties close to those of cancellous bone, QuickPack produces a calcium-deficient apatite that has similar composition and structure to natural bone mineral.

  • GlobeNewswire

    OrthoPediatrics Corp. Announces Closing of Common Stock Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

    OrthoPediatrics Corp. (“OrthoPediatrics”) (KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today the closing of its underwritten follow-on public offering of 1,805,500 shares of its common stock at a price to the public of $36.50 per share, which included the exercise in full by the underwriters of their option to purchase additional shares of common stock on the same terms and conditions. 1,755,500 of the shares were offered by OrthoPediatrics and 50,000 shares were offered by certain selling stockholders. Gross proceeds to OrthoPediatrics were approximately $64.1 million, before deducting underwriting discounts and commissions and offering expenses payable by OrthoPediatrics.

  • GlobeNewswire

    OrthoPediatrics Corp. Announces Pricing of Offering of Common Stock

    OrthoPediatrics Corp. (“OrthoPediatrics”) (KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today the pricing of its underwritten public offering of 1,570,000 shares of its common stock at a price to the public of $36.50 per share. 1,520,000 of the shares are being offered by OrthoPediatrics and 50,000 shares are being offered by certain selling stockholders. OrthoPediatrics will not receive any proceeds from the sale of the shares by the selling stockholders.

  • GlobeNewswire

    OrthoPediatrics Corp. Announces Proposed Public Offering of Common Stock

    OrthoPediatrics Corp. (“OrthoPediatrics”) (KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today that it is commencing an underwritten public offering of its common stock. OrthoPediatrics and certain of its stockholders are proposing to sell shares of common stock, including shares to be offered by certain selling stockholders. OrthoPediatrics will not receive any proceeds from the sale of the shares by the selling stockholders.